Citadel Advisors’s WaferGen Bio-systems, Inc. WGBS Stock Holding History

Citadel Advisors’s Portfolio WGBS Stock Details WGBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,417	Closed	-$19K	–	8291
2016 Q3	$19K	Buy	4,417 +2,125	+93%	+$9.52K	﹤0.01%	7080
2016 Q2	$9K	Sell	2,292 -16,232	-88%	-$60.5K	﹤0.01%	6735
2016 Q1	$59K	Buy	18,524 +6,271	+51%	+$20.1K	﹤0.01%	6214
2015 Q4	$45K	Buy	12,253 +8,445	+222%	+$41.9K	﹤0.01%	7409
2015 Q3	$26K	Buy	+3,808	New	+$34.9K	﹤0.01%	8025

Other funds holding WGBS

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Citadel Advisors's WGBS Position: Q4 2016 in Review

Citadel Advisors sold out of WaferGen Bio-systems, Inc. (WGBS) in Q4 2016, closing a stake of 4,417 shares — an estimated $19K sold.

Citadel Advisors first reported a position in WGBS in Q3 2015 and held it in 5 quarters. The position peaked at $59K in Q1 2016. 9 funds tracked by Wall St. Rank hold WGBS as of Q4 2016.

Citadel Advisors reported no remaining WaferGen Bio-systems, Inc. position as of Q4 2016 after selling out during the quarter.
Citadel Advisors sold 4,417 WaferGen Bio-systems, Inc. shares in Q4 2016, an estimated $19K.
Citadel Advisors first reported a position in WaferGen Bio-systems, Inc. in Q3 2015 and held it in 5 quarters.
Citadel Advisors's WaferGen Bio-systems, Inc. position peaked at $59K in Q1 2016.
9 funds tracked by Wall St. Rank held WaferGen Bio-systems, Inc. as of Q4 2016.

Based on Citadel Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.